|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Taylor S, Lam M, Pararasa C, Brown JE,
Carmichael AR and Griffiths HR: Evaluating the evidence for
targeting FOXO3a in breast cancer: A systematic review. Cancer Cell
Int. 15:12015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yuan B, Yoshino Y, Kaise T and Toyoda H:
Application of arsenic trioxide therapy for patients with leukemia.
Biological Chemistry of Arsenic, Antimony and Bismuth. Sun H: John
Wiley & Sons, Ltd; Chichester: pp. 263–292. 2011
|
|
4
|
Dilda PJ and Hogg PJ: Arsenical-based
cancer drugs. Cancer Treat Rev. 33:542–564. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chow SK, Chan JY and Fung KP: Suppression
of cell proliferation and regulation of estrogen receptor alpha
signaling pathway by arsenic trioxide on human breast cancer MCF-7
cells. J Endocrinol. 182:325–337. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu W, Gong Y, Li H, Jiang G, Zhan S, Liu
H and Wu Y: Arsenic trioxide-induced growth arrest of breast cancer
MCF-7 cells involving FOXO3a and IκB kinase β expression and
localization. Cancer Biother Radiopharm. 27:504–512. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang X, Gao P, Long M, Lin F, Wei JX, Ren
JH, Yan L, He T, Han Y and Zhang HZ: Essential role of cell cycle
regulatory genes p21 and p27 expression in inhibition of breast
cancer cells by arsenic trioxide. Med Oncol. 28:1225–1254. 2011.
View Article : Google Scholar
|
|
8
|
Kasukabe T, Okabe-Kado J, Kato N, Honma Y
and Kumakura S: Cotylenin A and arsenic trioxide cooperatively
suppress cell proliferation and cell invasion activity in human
breast cancer cells. Int J Oncol. 46:841–848. 2015.
|
|
9
|
Lin CC, Hsu C, Hsu CH, Hsu WL, Cheng AL
and Yang CH: Arsenic trioxide in patients with hepatocellular
carcinoma: A phase II trial. Invest New Drugs. 25:77–84. 2007.
View Article : Google Scholar
|
|
10
|
Vuky J, Yu R, Schwartz L and Motzer RJ:
Phase II trial of arsenic trioxide in patients with metastatic
renal cell carcinoma. Invest New Drugs. 20:327–330. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu T, Liu X and Li W: Tetrandrine, a
Chinese plant-derived alkaloid, is a potential candidate for cancer
chemotherapy. Oncotarget. 7:40800–40815. 2016.PubMed/NCBI
|
|
12
|
Fu LW, Zhang YM, Liang YJ, Yang XP and Pan
QC: The multidrug resistance of tumour cells was reversed by
tetrandrine in vitro and in xenografts derived from human breast
adenocarcinoma MCF-7/adr cells. Eur J Cancer. 38:418–426. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Y, Li P, Yang S, Tong N, Zhang J and
Zhao X: Tetrandrine enhances the anticancer effects of arsenic
trioxide in vitro. Int J Clin Pharmacol Ther. 52:416–424. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wei J, Liu B, Wang L, Qian X, Ding Y and
Yu L: Synergistic interaction between tetrandrine and
chemotherapeutic agents and influence of tetrandrine on
chemotherapeutic agent-associated genes in human gastric cancer
cell lines. Cancer Chemother Pharmacol. 60:703–711. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kon A, Yuan B, Hanazawa T, Kikuchi H, Sato
M, Furutani R, Takagi N and Toyoda H: Contribution of membrane
progesterone receptor α to the induction of progesterone-mediated
apoptosis associated with mitochondrial membrane disruption and
caspase cascade activation in Jurkat cell lines. Oncol Rep.
30:1965–1970. 2013.PubMed/NCBI
|
|
16
|
Wang X, Qi W, Li Y, Zhang N, Dong L, Sun
M, Cun J, Zhang Y, Lv S and Yang Q: Huaier extract induces
autophagic cell death by inhibiting the mTOR/S6K pathway in breast
cancer cells. PLoS One. 10:e01317712015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yuan B, Okusumi S, Yoshino Y, Moriyama C,
Tanaka S, Hirano T, Takagi N and Toyoda H: Delphinidin induces
cytotoxicity and potentiates cytocidal effect in combination with
arsenite in an acute promyelocytic leukemia NB4 cell line. Oncol
Rep. 34:431–438. 2015.PubMed/NCBI
|
|
18
|
Chen N and Karantza-Wadsworth V: Role and
regulation of autophagy in cancer. Biochim Biophys Acta.
1793:1516–1523. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mei L, Chen Y, Wang Z, Wang J, Wan J, Yu
C, Liu X and Li W: Synergistic anti-tumour effects of tetrandrine
and chloroquine combination therapy in human cancer: A potential
antagonistic role for p21. Br J Pharmacol. 172:2232–2245. 2015.
View Article : Google Scholar :
|
|
20
|
Lin CH, Chang CY, Lee KR, Lin HJ, Chen TH
and Wan L: Flavones inhibit breast cancer proliferation through the
Akt/FOXO3a signaling pathway. BMC Cancer. 15:9582015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang Y, Zou L, Lu WQ, Zhang Y and Shen
AG: Foxo3a expression is a prognostic marker in breast cancer. PLoS
One. 8:e707462013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chiacchiera F and Simone C: The
AMPK-FoxO3A axis as a target for cancer treatment. Cell Cycle.
9:1091–1096. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Y, Fu LX, Zhu WL, Shi H, Chen LJ and Ye
B: Blockade of CXCR6 reduces invasive potential of gastric cancer
cells through inhibition of AKT signaling. Int J Immunopathol
Pharmacol. 28:194–200. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ni D, Ma X, Li HZ, Gao Y, Li XT, Zhang Y,
Ai Q, Zhang P, Song EL, Huang QB, et al: Downregulation of FOXO3a
promotes tumor metastasis and is associated with metastasis-free
survival of patients with clear cell renal cell carcinoma. Clin
Cancer Res. 20:1779–1790. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chiu HW, Ho YS and Wang YJ: Arsenic
trioxide induces autophagy and apoptosis in human glioma cells in
vitro and in vivo through downregulation of survivin. J Mol Med
(Berl). 89:927–941. 2011. View Article : Google Scholar
|
|
26
|
Lee JY, Kuo CW, Tsai SL, Cheng SM, Chen
SH, Chan HH, Lin CH, Lin KY, Li CF, Kanwar JR, et al: Inhibition of
HDAC3-and HDAC6-promoted survivin expression plays an important
role in SAHA-induced autophagy and viability reduction in breast
cancer cells. Front Pharmacol. 7:812016. View Article : Google Scholar
|
|
27
|
Li Y, Liu D, Zhou Y, Li Y, Xie J, Lee RJ,
Cai Y and Teng L: Silencing of survivin expression leads to reduced
proliferation and cell cycle arrest in cancer cells. J Cancer.
6:1187–1194. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu W, Zhu F, Jiang Y, Sun D, Yang B and
Yan H: siRNA targeting survivin inhibits the growth and enhances
the chemosensitivity of hepatocellular carcinoma cells. Oncol Rep.
29:1183–1188. 2013.
|
|
29
|
Early Breast Cancer Trialists'
Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal
therapy for early breast cancer on recurrence and 15-year survival:
An overview of the randomised trials. Lancet. 365:1687–1717. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu ZL, Hirano T, Tanaka S, Onda K and Oka
K: Persistent reversal of P-glycoprotein-mediated daunorubicin
resistance by tetrandrine in multidrug-resistant human T
lymphoblastoid leukemia MOLT-4 cells. J Pharm Pharmacol.
55:1531–1537. 2003. View Article : Google Scholar
|
|
31
|
Wang TH, Wan JY, Gong X, Li HZ and Cheng
Y: Tetrandrine enhances cytotoxicity of cisplatin in human
drug-resistant esophageal squamous carcinoma cells by inhibition of
multidrug resistance-associated protein 1. Oncol Rep. 28:1681–1686.
2012.PubMed/NCBI
|
|
32
|
Wang YS, Zhou ST and Wei HL: Apoptosis
effects of drug sensitivity leukemia cells induced by nanorealgar.
Zhongguo Zhong Yao Za Zhi. 38:2202–2205. 2013.In Chinese.
PubMed/NCBI
|
|
33
|
Yoshino Y, Yuan B, Kaise T, Takeichi M,
Tanaka S, Hirano T, Kroetz DL and Toyoda H: Contribution of
aquaporin 9 and multidrug resistance-associated protein 2 to
differential sensitivity to arsenite between primary cultured
chorion and amnion cells prepared from human fetal membranes.
Toxicol Appl Pharmacol. 257:198–208. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chou TC: Drug combination studies and
their synergy quantification using the Chou-Talalay method. Cancer
Res. 70:440–446. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chou TC: Theoretical basis, experimental
design, and computerized simulation of synergism and antagonism in
drug combination studies. Pharmacol Rev. 58:621–681. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
El-Aarag BY, Kasai T, Zahran MA, Zakhary
NI, Shigehiro T, Sekhar SC, Agwa HS, Mizutani A, Murakami H, Kakuta
H, et al: In vitro anti-proliferative and anti-angiogenic
activities of thalidomide dithiocarbamate analogs. Int
Immunopharmacol. 21:283–292. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kikuchi H, Yuan B, Yuhara E, Takagi N and
Toyoda H: Involvement of histone H3 phosphorylation through p38
MAPK pathway activation in casticin-induced cytocidal effects
against the human promyelocytic cell line HL-60. Int J Oncol.
43:2046–2056. 2013.PubMed/NCBI
|
|
38
|
Kikuchi H, Yuan B, Yuhara E, Imai M,
Furutani R, Fukushima S, Hazama S, Hirobe C, Ohyama K, Takagi N, et
al: Involvement of histone H3 phosphorylation via the activation of
p38 MAPK pathway and intracellular redox status in cytotoxicity of
HL-60 cells induced by Vitex agnuscastus fruit extract. Int J
Oncol. 45:843–852. 2014.PubMed/NCBI
|
|
39
|
Zekri A, Ghaffari SH, Yousefi M,
Ghanizadeh-Vesali S, Mojarrad M, Alimoghaddam K and Ghavamzadeh A:
Autocrine human growth hormone increases sensitivity of mammary
carcinoma cell to arsenic trioxide-induced apoptosis. Mol Cell
Endocrinol. 377:84–92. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yuan B, Ohyama K, Takeichi M and Toyoda H:
Direct contribution of inducible nitric oxide synthase expression
to apoptosis induction in primary smooth chorion trophoblast cells
of human fetal membrane tissues. Int J Biochem Cell Biol.
41:1062–1069. 2009. View Article : Google Scholar
|
|
41
|
Yoshino Y, Yuan B, Miyashita SI, Iriyama
N, Horikoshi A, Shikino O, Toyoda H and Kaise T: Speciation of
arsenic trioxide metabolites in blood cells and plasma of a patient
with acute promyelocytic leukemia. Anal Bioanal Chem. 393:689–697.
2009. View Article : Google Scholar
|
|
42
|
Zhang Y, Dong Z, Jin L, Zhang K, Zhao X,
Fu J, Gong Y, Sun M, Yang B and Li B: Arsenic trioxide-induced hERG
K(+) channel deficiency can be rescued by matrine and oxymatrine
through up-regulating transcription factor Sp1 expression. Biochem
Pharmacol. 85:59–68. 2013. View Article : Google Scholar
|
|
43
|
Liu QY, Karpinski E and Pang PK:
Tetrandrine inhibits both T and L calcium channel currents in
ventricular cells. J Cardiovasc Pharmacol. 20:513–519. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ficker E, Kuryshev YA, Dennis AT,
Obejero-Paz C, Wang L, Hawryluk P, Wible BA and Brown AM:
Mechanisms of arsenic-induced prolongation of cardiac
repolarization. Mol Pharmacol. 66:33–44. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chow SK, Chan JY and Fung KP: Inhibition
of cell proliferation and the action mechanisms of arsenic trioxide
(As2O3) on human breast cancer cells. J Cell
Biochem. 93:173–187. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Scholz C, Wieder T, Stärck L, Essmann F,
Schulze-Osthoff K, Dörken B and Daniel PT: Arsenic trioxide
triggers a regulated form of caspase-independent necrotic cell
death via the mitochondrial death pathway. Oncogene. 24:1904–1913.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liu T, Men Q, Wu G, Yu C, Huang Z, Liu X
and Li W: Tetrandrine induces autophagy and differentiation by
activating ROS and Notch1 signaling in leukemia cells. Oncotarget.
6:7992–8006. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang L, Shamaladevi N, Jayaprakasha GK,
Patil BS and Lokeshwar BL: Polyphenol-rich extract of Pimenta
dioica berries (Allspice) kills breast cancer cells by autophagy
and delays growth of triple negative breast cancer in athymic mice.
Oncotarget. 6:16379–16395. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang H, Liu T, Li L, Wang Q, Yu C, Liu X
and Li W: Tetrandrine is a potent cell autophagy agonist via
activated intracellular reactive oxygen species. Cell Biosci.
5:42015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chiu HW, Lin JH, Chen YA, Ho SY and Wang
YJ: Combination treatment with arsenic trioxide and irradiation
enhances cell-killing effects in human fibrosarcoma cells in vitro
and in vivo through induction of both autophagy and apoptosis.
Autophagy. 6:353–365. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tsai JH, Hsu LS, Huang HC, Lin CL, Pan MH,
Hong HM and Chen WJ:
1-(2-Hydroxy-5-methylphenyl)-3-phenyl-1,3-propanedione induces G1
cell cycle arrest and autophagy in HeLa cervical cancer cells. Int
J Mol Sci. 17:172016. View Article : Google Scholar
|
|
52
|
Tamm I, Wang Y, Sausville E, Scudiero DA,
Vigna N, Oltersdorf T and Reed JC: IAP-family protein survivin
inhibits caspase activity and apoptosis induced by Fas (CD95), Bax,
caspases, and anticancer drugs. Cancer Res. 58:5315–5320.
1998.PubMed/NCBI
|
|
53
|
Chen X, Duan N, Zhang C and Zhang W:
Survivin and tumorigenesis: Molecular mechanisms and therapeutic
strategies. J Cancer. 7:314–323. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Doyle LA, Yang W, Abruzzo LV, Krogmann T,
Gao Y, Rishi AK and Ross DD: A multidrug resistance transporter
from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA.
95:15665–15670. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sertel S, Tome M, Briehl MM, Bauer J, Hock
K, Plinkert PK and Efferth T: Factors determining sensitivity and
resistance of tumor cells to arsenic trioxide. PLoS One.
7:e355842012. View Article : Google Scholar : PubMed/NCBI
|
